Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine vs Cetirizine vs Placebo in CIU
NCT00751218Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- May 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of desloratadine in chronic idiopathic urticaria (CIU) (3 arms), sponsored by Organon & Co. Primary endpoint: Change from Baseline in Average AM/PM 12-hour Reflective Pruritus Severity Score at 7 days. Started May 2004; status: completed.
02
Drugs
desloratadine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT00751218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751218.